You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 2, February 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Diurnal Variation in Plasma Homovanillic Acid Level Persists but the Variation in 3-Methoxy-4-hydroxyphenylglycol Level Is Abolished Under Constant Conditions

David A. Sack, MD; Steven P. James, MD; Alan R. Doran, MD; Michael A. Sherer, MD; Markku Linnoila, MD, PhD; Thomas A. Wehr, MD

Arch Gen Psychiatry. 1988;45(2):162-166.


Abstract

• Plasma concentrations of homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenylglycol (MHPG) were determined every two hours for two consecutive days in seven depressed patients and seven matched normal controls. On the first day subjects followed their regular ward routine. On the second day they were placed on a regimen in which activity, posture, diet, and wakefulness were held constant. There were significant diurnal variations in both MHPG and HVA concentrations on the baseline day, whereas on the constant routine, a diurnal variation was present only in HVA. We conclude that diurnal variations in plasma MHPG are evoked by changes in physical activity, posture, or other factors controlled on the constant routine, and that a major component of the diurnal variation in plasma HVA concentrations is regulated by a circadian oscillator that is independent of sleep or activity.



Author Affiliations

From the Clinical Psychobiology Branch, National Institute of Mental Health (Drs Sack, James, and Wehr), the National Institute of Drug Abuse (Dr Sherer), and the Laboratory of Clinical Studies, Division of Intramural and Biological Research, National Institute on Alcohol Abuse and Alcoholism (Dr Linnoila), National Institutes of Health, Washington, DC; and University of California, Davis (Dr Doran). Dr Sack is now with Los Altos Hospital, Los Altos, Calif.


Footnotes

Accepted for publication July 7, 1987.

Reprint requests to National Institutes of Health, Bldg 10, Room 4 S 239, Washington, DC 20892 (Dr Wehr).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuroleptic Treatment, Symptoms of Schizophrenia, and Plasma Homovanillic Acid Concentrations Revisited-Reply
DAVIDSON et al.
Arch Gen Psychiatry 1992;49:1000-1000.
ABSTRACT  

Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT  

Circadian Variation of Plasma Homovanillic Acid Levels Is Attentuated by Fluphenazine in Patients With Schizophrenia
Doran et al.
Arch Gen Psychiatry 1990;47:558-563.
ABSTRACT  

Effects of Renal Clearance on Plasma Concentrations of Homovanillic Acid: Methodologic Cautions
Potter et al.
Arch Gen Psychiatry 1989;46:558-562.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.